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Abstract
The presence of noise or errors in the stated feature values of
biomedical data can lead to incorrect prediction. We intro-
duce a Bayesian Network-based Noise Correction framework
named BN-NC. After data preprocessing, a Bayesian Net-
work (BN) is learned to capture the feature dependencies.
Using the BN to predict each feature in turn, BN-NC esti-
mates a feature’s error rate as the deviation between its pre-
dicted and stated values in the training data, and allocates
the appropriate uncertainty to its subsequent findings during
prediction. BN-NC automatically generates a probabilistic
rule to explain BN prediction on the class variable using the
feature values in its Markov blanket, and this is reapplied
as necessary to explain the noise correction on those fea-
tures. Using three real-life benchmark biomedical data sets
(on HIV-1 drug resistance prediction and leukemia subtype
classification), we demonstrate that BN-NC (1) accurately
detects the errors in biomedical feature values, (2) automat-
ically corrects for the errors to maintain higher prediction
accuracy over competing methods including Decision Trees,
Naive Bayes and Support Vector Machines, and (3) gener-
ates probabilistic rules that concisely explain the prediction
and noise correction decisions. In addition to achieving more
robust biomedical prediction in the presence of feature noise,
by highlighting erroneous features and explaining their cor-
rections, BN-NC provides medical researchers with high util-
ity insights to biomedical data not found in other methods.
1 Introduction
Medical doctors and biomedical researchers are increas-
ingly interested in adopting machine learning tools to
mine high-dimensional biomedical data sets for critical
tasks including personalized medicines and population-
wide disease screening. An example is the use of serum
proteomic data from mass spectrometry for ovarian can-
cer screening, where the classifier has to be trained on
hundreds of thousands of mass-to-charge (M/Z ) intensi-
ties [1]. Another scenario uses DNA microarray expres-
sions to differentiate the acute leukemia subtypes, where
again many thousands of expressions are involved [2].
Where such massive volumes of genotypic features
have to be monitored in a lab environment, issues such
as electronic noise, chemical contamination, hybridiza-
tion, and microarray spots irregularities often arise un-
detected. As a result, noise or unexpected errors in the
recorded feature values are common [3, 4, 5]. Such errors
are even more rampant if the feature values have to be
manually-curated into data repositories, such as in the
case of the single-nucleotide polymorphisms (SNPs) be-
ing used in genome wide association (GWA) studies [6].
To address the noise in biomedical data, the classi-
fier has to identify the erroneous features and take into
account the uncertainty in each presented value to make
the right prediction. It is also necessary for the predic-
tion to be explained to users, especially since biomedical
prediction usually has serious consequences (e.g. cancer
screening). Current methods for biomedical prediction
such as decision tree and support vector machines can-
not detect nor correct for noise, and this can lower the
accuracy of the biomedical prediction significantly [7, 1].
In many cases, dependencies can be observed among
the biomedical features, and this input redundancy can
cancel out some of the noise. Indeed, our earlier research
has shown that by effectively exploiting the captured de-
pendencies among the biomedical features in a Bayesian
network (BN) [8], we can achieve robust ovarian cancer
detection using real-world serum proteomic features [1].
This is possible because whilst classifiers such as the de-
cision tree, naive Bayes and support vector machine are
only effective at capturing associations from features to
the class variable, the probabilistic causal model of BN
encapsulates the dependencies between features. Never-
theless, noise corrections cannot take place or are inef-
fective as long as the identities of the erroneous features
and their probabilities of error remain undetected, and
any explanation for BN prediction based on the wrongly
recorded feature values would only confuse the users.
In this paper, we introduce the Bayesian Network
with Noise Correction (BN-NC) framework. Capturing
feature dependencies by learning a BN, BN-NC uses the
BN to predict each feature in turn, and estimates its
error rate using the proportion of mismatches between
its predicted and stated values in the training data. This
error estimate is presented to BN as the uncertainty in
that feature, so that BN can accord the right amount of
confidence to that feature’s stated values in subsequent
predictions. A probabilistic rule is generated to explain
each BN prediction using the feature values in the class
variable’s Markov blanket. Where a feature’s value
during prediction differs from its stated value, BN-
NC explains the correction on that feature value in a
recursive manner.
Our related work on ovarian cancer detection has, to
a preliminary extent, demonstrated the effectiveness of
exploiting feature dependencies for accurate prediction.
Here, a much more rigorous empirical analysis is pre-
sented to substantiate some of the claims in BN-NC that
are important for noisy biomedical prediction. Specifi-
cally, we systematically answer the following questions:
• Suppose the true error rates of biomedical features
are known, can BN-NC accurately identify all those
erroneous features and estimate their error rates?
• In the presence of noise, does BN-NC outperform
standard BN, decision tree, naive Bayes, and sup-
port vector machines, all of which are the popular
machine learning tools for biomedical prediction?
We conduct a controlled experiment by introducing
different severity of feature noise into the HIV-1 data set
from the Stanford HIV Drug Resistance Database [9].
This pseudo-natural setup allows us to control the size of
noise in specific features to verify whether the different
levels of added noise are correctly detected by BN-NC,
and furthermore, how accurate is BN-NC compared to
decision tree, naive Bayes and support vector machine.
• The BN-NC explanation procedure uses features in
the class variable’s Markov blanket to explain BN
prediction. In the learned BNs, do the features in
the class variable’s Markov blankets really possess
known biomedical association to the class variable?
We verify that the BN learned using the HIV-1 data
contains known resistance mutations as the class vari-
able’s Markov nodes by learning the BN models from
many independent data partitions and summarizing the
frequencies with which known mutations (e.g. TAMs)
appear within the class node’s learned Markov blanket.
• DNA microarray is a prevalent source of data used
for biomedical prediction today. Does feature noise
really exist in real-world microarray data sets, and
how does the BN-NC framework perform for them?
Finally, we evaluate the prediction accuracy of BN-
NC using two real benchmark DNAmicroarray data sets
for acute leukemia subtype classifications. The empiri-
cal results demonstrate that BN-NC effectively detects
naturally-occurring noisy features, and by appropriately
accounting for the noise, performs comparably or better
than classifiers including DT and SVM, while addition-
ally giving valuable comprehension to BN’s predictions.
The rest of this paper is organized as follows. Sec-
tion 2 introduces the proposed Bayesian Network with
Noise Correction (BN-NC) framework. Section 3 elabo-
rates on the specific problems of HIV-1 drug resistance
prediction based on DNA mutations and acute leukemia
subtype classification using gene expressions, our prepa-
ration of the corresponding benchmark data sets, as well
as the evaluation measure and baseline methods used for
comparison in the experiments. Section 4 presents and
discusses the results and Section 5 concludes this paper.
2 Bayesian Network with Noise Correction
(BN-NC) Framework
Algorithm 1 summarizes the proposed Bayesian network
with Noise Correction (BN-NC) framework, which sys-
tematically brings the noisy biomedical data set through
the steps of preprocessing, model extraction, noise dis-
covery, and diagnosis with explanation (as visualized in
Figure 1). We describe the details of these steps below.
2.1 Step 1 - Select Useful Features Our data
preprocessing focuses on selecting the useful features
and discretizing them for BN model learning. We
implement the entropy-based discretization and feature
Noisy
data set
1. Data
preprocessing
2. BN learning
from data
3. Error
discovery
4. Prediction with
explanation End
Figure 1: The Bayesian Network with Noise Correction (BN-NC) framework.
Algorithm 1 The Complete BN-NC Framework
Input: Training data (train), test data (test), and
error threshold (t).
Output: BN learned from train, erroneous features
(F ) with error rates (R), inferences (I) on test, and
explanations (E) for I.
Step 1: Select Useful Features
Let A be the set of attributes in train.
for each attribute a ∈ A do
if a does not separate the target classes then
A = A− a.
Step 2: Capture Feature Dependencies
Select the top-k most-informative features (top A).
Learn BN from train based on top A.
Step 3: Estimate Error Rates of Features
Identify F and estimate R values using Algorithm 2.
Step 4: Predict with the Noisy Features
for each test case ci ∈ test do
Estimate likelihoods of F , based on R and case ci.
Enter ci into BN to obtain inference i; I = I + i.
Generate explanation e for inference i; E = E + e.
return BN and the sets F , R, I, and E.
selection technique from Fayyad and Irani [10], which
has been applied successfully, e.g. in [1], to preprocess
other bio-data. The Fayyad-&-Irani technique combines
the entropy-based splitting criterion of the C4.5 decision
tree [11] with the minimum description length (MDL)
stopping criterion. It finds the optimal cutting point
for every feature so as to maximize its separation of the
classes. Features without cutting points are discarded,
effectively reducing the dimensions while converting
the continuous features into discrete features to enable
learning of discrete BN models. Other preprocessing
methods can also be applied as part of this step, e.g. [12].
2.2 Step 2 - Capture Feature Dependencies We
sort the discretized features in decreasing order of in-
formation gain, which measures the reduction in en-
tropy obtained by splitting the training data on each
feature, and learn a BN model based on the top-k most-
informative features (the value of k is automatically se-
lected via cross-validation using the training data). This
enables BN-NC to capture the feature dependencies,
something that methods such as SVM are unable to do.
In this work, the CaMML BN learning program [13] is
adopted. CaMML stochastically compares all the pos-
sible models to maximize a minimum message length
(MML) posterior metric [13]. For each visited model, it
computes a representative model and sets the represen-
tative’s posterior as the sum posterior of its members.
Each aggregated posterior approximates the probability
that the true model lies within the MML equivalence
class of a representative, so the representative with the
largest MML posterior is the best model. In our expe-
rience, accurate biological causal models can usually be
found based on fewer than thirty informative attributes
(e.g. [1]), and CaMML learns a BN of this size in just a
few minutes. Alternative methods like constraint-based
BN model learning [13] can also be applied in this step.
2.3 Step 3 - Estimate Error Rates of Features
A data feature is potentially erroneous or noisy if it
carries its observations with some error probability. An
error rate or probability of e for a feature f implies that
observations for f are wrong e*100% of the time. In
practice, we do not know how many and which features
are erroneous, so we need to be able to discover multiple
erroneous features, and to estimate the error rate for
each of them. As presented in Algorithm 2, the error
discovery procedure takes in the training cases and also
the corresponding learned BN. Predicting with the BN
and using the proportion of misclassified training cases
to estimate each feature’s error rate, the procedure
identifies the feature that is most likely to be erroneous,
based on the intuition that the noisiest feature would
be the one that is least predictable by the learned BN.
For each training case, the procedure enters all the
evidence except for the feature being investigated and
exploits the captured causal dependencies between that
feature and the rest of the network to predict its value.
After the most likely erroneous feature is identified, the
procedure enters that feature’s value for each training
case as a likelihood finding, or a soft evidence, while it
searches for the next most likely erroneous feature in
a similar manner. The process is repeated to find the
third most erroneous feature, and so forth - it terminates
Algorithm 2 Error Discovery in BN-NC
Input: Training data (train), BN from train, and
error threshold (t).
Output: Erroneous features (F ), and their correspond-
ing error rates (R).
Step 1: Identify the top erroneous feature ftop.
for each feature fi do
for each record ∈ train do
Cover-up fi and predict its value using BN .
Perr(fi) = fraction of train that fi is misclassified.
ftop = argmax(Perr(fi)), max err = Perr(ftop).
if max err < t then return F and R as empty sets.
else F = F + ftop, R = R + max err.
Step 2: Identify the rest of sets F and R.
min err = Perr(ftop).
while ∃ feature /∈ F ∧ min err ≥ t do
for each feature fi 6∈ F do
for each record ∈ train do
Estimate likelihoods L for feature values in F .
Cover-up fi; predict its value with BN and L.
Perr(fi) = fraction of train with fi misclassified.
fnext = argmax(Perr(fi)), max err = Perr(fnext).
F = F + fnext; R = ∅.
for each feature fi ∈ F do
R = R + Perr(fi).
fleast = argmin(Perr(fi)), min err = Perr(fleast).
if min err < t then F=F -fleast, R=R-Perr(fleast).
return the non-empty sets F and R.
only when the error rates for all the features have been
estimated, or until the minimum detected error rate falls
below a particular threshold. The error threshold allows
experts to ignore trivial degrees of natural randomness
in the features’ values; in our experience, a suitable error
threshold would be 0.1 or less, so that as many of the
erroneous features in the data are identified as possible.
2.4 Step 4 - Predict with the Noisy Features
2.4.1 Likelihoods Estimation We expect the test
data to be noisy too, with a noise characteristic similar
to the training data. Inputting the features’ values as
specific findings, or hard evidence, is very likely to result
in wrong predictions if those findings are incorrect. The
BN allows us to specify such potentially noisy findings as
likelihoods or soft evidence to reflect their uncertainties.
To illustrate, suppose a feature f has three possible
values in V :{0, 1, 2}, and it is observed to have one of
these values (this observation is hereafter denoted as o).
The likelihoods of o are the conditional probabilities of
o given the true value vf of feature f , i.e., likelihoods of
o are {prob(o|vf = 0), prob(o|vf = 1), prob(o|vf = 2)}.
Now suppose o is {f = 1}, and f carries an error
rate of e (rate e could be approximated from the training
data using Algorithm 2). The likelihoods for o are then
{P (0) ∗ e, (1.0 − e), P (2) ∗ e}, where P (v) is the prior
probability of value v (approximated by the proportion
of the training data for which v was observed). This is
because the likelihood of observing {f = 1} when vf = 0
or vf = 2 is the probability that one of these other values
is present in the example but we make an error, whilst
the likelihood of observing {f = 1} when vf = 1 is the
probability of not making an error. We generalize this
likelihoods estimation below, where entering a error rate
of 0.0 is akin to entering the evidence with full certainty:
Likelihood of o for the observed value v = (1.0− e),
Likelihood of o for value v′ ∈ {V − v} = P (v′) ∗ e.
2.4.2 Explaining the BN Inferences Our BN-NC
framework seamlessly integrates the recent Explaining
BN Inferences (EBI) procedure [14] to automatically
generate explanations for BN inferences. EBI explains
the value of a target node using just the contextually in-
fluential nodes in its Markov blanket (the target node’s
parents, children, and spouses). This is necessary and
sufficient because conditional independence implies that
the Markov values form a minimal set that fully ex-
plains the inferences. To simplify its explanations, EBI
exploits the context-specific independence reflected in
the target node’s conditional probabilities. Working
back from the target node, EBI shows the derivation
of each intermediate variable in terms of their own re-
spective Markov nodes, thereby explaining how missing
and noisy evidence values are corrected during inference.
EBI’s ability to explain the noise corrections during BN
prediction is not found in any other methods, e.g., [15].
The EBI procedure consists of three key steps.
First, EBI restructures the local dependencies around
the target node (or the class variable) via a series of arc
reversals, such that its Markov nodes become its parents
while maintaining the joint distribution. The resulting
conditional probability table (CPT) of the target node
describes its probability distribution over all its Markov
value combinations. Next, EBI simplifies the rules that
it would generate, by learning from the target CPT
a decision tree (DT) that captures the context-specific
independence among the Markov nodes for each target
value. Finally, during the inference, EBI compares the
assigned Markov values against the DT for the predicted
target value, and explains the prediction in terms of the
nodal values along the DT path for the current context.
3 Experiment Setup
3.1 Problem Domains
3.1.1 HIV-1 Drug Resistance Prediction HIV-1
drug resistance arises when, after the consumption of a
drug by a patient, the amino acids in parts of her HIV-1
virus mutate to increase its resistance against that drug.
Therapies that administer antiretroviral drugs for which
the patient’s virus is highly resistant are ineffective; not
only might the virus develop new mutations making it
less susceptible to similar drugs (a condition known as
cross-resistance), the patient suffers unnecessarily from
the ineffective antiretroviral drugs’ adverse side-effects.
Recently, a variety of computational approaches
have been used to predict a patient’s drug resistance
based on mutations, including linear regression [16] and
support vector machines (SVM) [17]. In [17], Saigo et al.
commented that no existing methods “can achieve high
accuracy and good interpretability at the same time”;
as such, they developed an itemset-boosting technique
which extracts linear regression rules using mutation
associations (complex features) as predicates. Itemset-
boosting assumes that predicates (complex / singular
features) combine linearly to predict the resistance out-
come. There is no knowledge of how those features in-
teract to influence the drug resistance, nor how the sin-
gular features in each mutation association are related.
To better understand the roles played by the drug-
resistance mutations, other works have turned to the
Bayesian network (BN) [18]. Our approaches are signif-
icantly different in a number of ways. First, the works of
Deforche et al. [18] tried to understand the evolution of
drug resistance during treatments. In contrast, we aim
to discover a model of salient mutations that predicts
the virus’s resistance to a specific drug, or a drug class;
mutations need not be the in vivo reactions to previ-
ous consumption of the drug, but instead can be results
of site-directed mutagenesis where resistance levels are
determined in vitro [16]. So, while the prior BN works
focused on learning to interpret mutational responses by
HIV-1 after taking a drug, we are the first to analyze
BN’s accuracy for the prediction of HIV-1 resistance.
While Deforche et al. [18, 19] focused on the phar-
macological effects of drugs in the protease inhibitor
(PI) family (e.g. nelfinavir), we opt to discover a prob-
abilistic model of mutations that can predict a patient’s
level of resistance against the nucleotide reverse tran-
scriptase inhibitor (NRTI) drug known as Tenofovir
(TDF). Our study on TDF is motivated by the knowl-
edge that for NRTIs, only combinations of multiple mu-
tations can increase HIV-1’s resistance to drugs, and it
has been found that salient large mutation associations
are more common for NRTIs than other drugs [17].
3.1.2 Acute Leukemia Subtype Classification
More than 40,000 new cases and 20,000 leukemia-related
deaths were expected in the United States of America
alone last year [20]. Leukemia, or cancer of the blood,
has heterogeneous subtypes with diverse responses to
different forms of therapies [21]. Misdiagnosis result in
inappropriate therapies that can lead to excess toxicity
and low survival rate [2], so recognizing the leukemia
subtype is a critical step in the treatment of leukemia.
Microarray expressions are known to be noisy [3,
4, 5], and unknown errors in the expression or feature
values can misguide standard classification methods to
make wrong predictions. It is therefore important that
our noise correction framework can reliably identify the
errors among the observations and effectively correct for
them during predictions. In addition to a highly robust
accuracy, a desirable leukemia subtype classification
method should also be able to explain to the user how
important genes had interacted to derive the diagnosis.
These modelled behaviors may then be verified clinically
by experts. Unfortunately, most existing methods give
“black-box” classifiers which do not provide users with
sufficient comprehension on the classification outcomes.
3.2 Data Source and Data Preparation
3.2.1 HIV-1 Drug Resistance Prediction It is
hard to ascertain using available data sets that a given
approach can indeed find those features that are truly
noisy. This is because no one knows which of the fea-
ture values are wrong (if so, these would have been
corrected). In view of this, it is necessary to demon-
strate through simulated experiments that a process
finds noisy features. The HIV-1 domain was chosen
because mutation associations influencing resistance to
each drug are relatively established, allowing us to ob-
jectively verify whether BN learning can recover these
associations. In addition, by explicitly introducing dif-
ferent rates of errors to mutations, we can objectively
compare the performance of BN-NC against competing
methods within identical setups of noisy environment.
We use the real-life HIV-1 data set from the Stan-
ford HIV Drug Resistance Database [9] for our con-
trolled experiments, where different degrees of errors
are injected into the mutations in the isolates’ DNA
sequences of patients and their level of resistance to the
nucleotide reverse transcriptase inhibitor (NRTI) drug
known as Tenofovir (TDF) are predicted. We use the
complete mutation set prepared by Rhee et al. [16]. In
the data, mutations are defined as amino acid differ-
ences from subtype B consensus wild-type sequence [9].
Each mutation is represented with a position index
flanked by the acid’s subtype before and after muta-
tion. For example, “M41L” refers to mutation of amino
acid M into amino acid L at position 41 of the sequence.
There are three discrete levels of drug resistance
(“Susceptible”, “Intermediate” and “High-level”). The
data set for drug TDF comprises 353 isolates (in-
stances), of which 70% are labelled “Susceptible”, 18%
are “Intermediate”, and the remaining 12% are “High-
level”. There are a total of 348 mutations (features) in
this data. The errors are introduced into the data by
randomly flipping the mutation values in the samples
according to the intended error rate. For example, to in-
troduce an error rate of x into mutationm, we randomly
flip x*100% of m’s values among the data samples.
In all the HIV-1 experiments, we performed ten in-
dependent rounds of stratified five-fold cross validation
(10x5-fold cross-validation) to ensure better statistical
stability [22]. In each round, data samples are randomly
partitioned into five equal-sized parts, where each part
contains approximately the same distribution of class
labels as the overall data. We then perform five inde-
pendent validations using this partitioning, each time
leaving out one of the five parts for testing and using
the remaining four parts to train. A total of fifty such
validations are performed to get the average accuracy.
3.2.2 Acute Leukemia Subtype Classification
By introducing errors into the previous HIV-1 data set,
we would have effectively addressed our first three ques-
tions stated in Introduction (Section 1). In this second
series of experiments, we will evaluate whether the BN-
NC framework performs accurately on DNA microarray
data given their natural noise characteristics, using two
publicly-available acute leukemia gene expression data
sets: the ALL/AML data set [2] provided by the Broad
Institute Cancer Program, and the Pediatric ALL data
set [23] provided by the Saint Jude Children’s Research
Hospital.
The ALL/AML data set classifies acute leukemia
tumor samples into Acute Lymphoblastic Leukemia
(ALL) and Acute Myeloid Leukemia (AML) using gene
expressions [2]. The publicly-available data set com-
prises 38 training cases (with 27 ALL and 11 AML
cases) and 34 test cases (20 ALL and 14 AML cases).
For comparison with prior results, we adopt these origi-
nal data partitions in our experiments. There are a total
of 7,129 genes (i.e., features) in the ALL/AML data set.
The Pediatric ALL data set classifies 327 Acute
Lymphoblastic Leukemia (ALL) tumor samples from
children into six subtypes based on their gene expres-
sions [23]. The training set comprises 215 examples, and
another 112 examples are provided for testing. Depend-
ing on which one of the six subtypes is to be classified,
an example in the data is either labelled as “belonging”
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Figure 2: The initial error rates detected for TDF.
or “not belonging” to that ALL subtype [23]. In our
experiments, we adopt the original data partitioning in
order for direct comparison with the previous results.
3.3 Performance Evaluation and Baselines We
used prediction accuracy, or the proportion of test in-
stances that are correctly predicted, as our performance
evaluation measure. In other words,
accuracy =
||correct||
||test||
(3.1)
where ||correct|| and ||test|| denote the number of test
instances whose labels are correctly predicted and the
total number of test instances, respectively.
Within identical setups of noisy environment, we
compare performance of standard BN against BN aided
by noise correction (BN-NC), using the J4.8 (or C4.5)
decision tree (DT) [11], naive Bayes (NBayes) [24] and
support vector machine (SVM) classifiers as the baseline
methods (these baseline methods are available within
the WEKA software [25]; we use the WEKA implemen-
tations and its default settings for all our experiments).
The C4.5 DT classifier, which does not capture feature
dependencies, is a suitable baseline because it has been
shown to perform as well as standard BN when there
is no feature noise [26]. Similarly, NBayes, which as-
sumes independence among all data features, is suitable
because it has been shown to outperform other much
more complicated machine learning methods [27]. SVM
is chosen as a baseline due to its generalization ability
and popularity in medical classification research [28, 29].
The effectiveness of considering feature dependencies
under BN-NC would be well supported if it performs
better in presence of noise than basic BN, DT, NBayes
and SVM.
4 Results and Discussions
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Figure 3: Test prediction accuracies for TDF (the plots
for SVM, DT and BN overlap as the lowest line). BN-
NC (the highest line in the figure) outperforms the other
methods especially when error rate introduced is larger.
4.1 HIV-1 Drug Resistance Prediction With no
noise added, we learned BNs from the fifty training sets
using the top-5 most informative features in each set.
The Markov blankets of the learned BNs involved just
the following seven mutations: T69i, L210W, L228H,
M41L, T200A, D67N, and M184V. The BN-NC frame-
work detected some initial noise in the seven mutations
and Figure 2 shows the automatically detected initial
error rates in decreasing order. The mutation values
within this HIV-1 data set appear to be rather “clean”,
with the average detected error rate being just 0.18. The
cross-validation accuracy of BN-NC was 0.697, which
was higher than the mean accuracy of 0.652 reported for
drug TDF in [16]. Even though the mutations did not
appear to contain a lot of noise, BN-NC was able to out-
perform Support Vector Machine (SVM), Naive Bayes
(NBayes), J4.8 Decision Tree (DT), and BN without
noise correction when no additional noise was injected.
Figure 3 presents the accuracies obtained from each
method when we apply them on identical training and
test splits with various degrees of noise introduced. The
same error rate was added to each of the seven mutation
features covered by the Markov blankets. For example,
to introduce an error rate of 0.3, 30% of values for each
of the seven mutations were randomly-picked from the
entire data set and flipped. No error was introduced to
the only other mutation, T215Y, that was learned in the
BNs but not covered by any of the Markov blankets.
J4.8 DT and standard BN classifier performed very
similarly during the evaluation, so much so that their
lines in the chart of Figure 3 overlap. This is consistent
with previous observations that DT and BN predict
similarly without noise correction [26]. SVM only
performed slightly worse than BN-NC with no noise
added, but it’s performance quickly converged with
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Figure 4: Increase in the BN-NC detected error rates
over the initial error rates detected for TDF (the plot
for mutation T215Y overlaps with the horizontal axis).
The horizontal axis indicates the error rate that was
introduced to every one of the mutations except T215Y.
DT and BN without noise correction once the errors
were injected. NBayes performed worse than the other
methods with no noise added because its assumption
of complete feature independence did not match the
fact that the real-world data contains inherent feature
dependencies; its accuracy increased marginally with a
small noise added possibly because the noise reduced the
feature dependency and suited it. However, NBayes was
substantially outperformed by BN-NC with more noise
added to the mutations such that their erroneous values
become less and less predictive of resistance. Overall,
BN-NC maintained an accuracy close to 0.7 even when
the error rate was raised to 0.4, while all the competing
methods (SVM, NBayes, DT and the BN without noise
correction) suffered a far greater drop in their accuracy.
To verify whether the proposed error discovery pro-
cedure can indeed sense the scale of the introduced noise
correctly, we analyze, for various mutations, the differ-
ence between the detected error rate at each degree of
introduced noise and the detected rate (shown in Fig-
ure 2) when no noise has been introduced. If the noise
detection procedure works properly, we expect to see
a steady rising trend in each mutation’s detected error
rate as we add more noise. As shown in Figure 4, this
is indeed the case. For each of the seven mutations in
which noise was added, the detected error rate increases
steadily as more noise is introduced to the mutations.
The BN-NC procedure also correctly concludes that no
additional noise was introduced to the mutation T215Y,
which is represented by the only flat line in the figure.
The differences in the slopes for the different muta-
tions are due to differences in the initial detected error
rate, i.e., when no additional noise has been introduced
and the mutation values contain only their inherent er-
rors. This is because the additional errors are intro-
duced into the data by randomly flipping the mutation
Table 1: Frequency of mutations in Markov blankets.
Mutation Frequency Is TAM Is Q151M-complex
D67N 40 Yes No
M41L 30 Yes No
L210W 26 Yes No
T69i 5 No No
L210W & D67N 26 Yes No
values in the samples according to the intended rate,
which means that some of the inherent errors are un-
knowingly flipped in the process. A mutation with a
smaller initial rate would have a steeper slope in Fig-
ure 4, because most of the randomly administered flips
would have added on to the existing errors in the data
set. Indeed, the lower the initial detected error rate for
a mutation in Figure 2, the steeper the error increment
that was detected for that mutation in Figure 4. The
above results completely verify that the proposed noise
detection procedure can indeed accurately detect not
only the inherent error rates, but also the different de-
grees of noise that we introduced into the mutation fea-
tures’ values during the above controlled experiments.
Our next task is to verify if the learned BN captures
known drug-resistance mutations in the class variable’s
Markov blanket. In drug resistance studies, a mutation
selected by the virus as the first mutation to increase its
resistance against a certain drug is referred to as amajor
mutation, and a mutation that is selected to increase
resistance only in the presence of some other mutations
is a minor mutation. We now verify whether well-known
major and minor mutations are correctly recovered as
part of the class variable’s Markov blankets in the BNs;
this would in turn validate the rationale underlying BN-
NC’s Markov blanket-based explanation procedure.
The NRTI family of antiretroviral drugs targets the
reverse transcriptase (RT) DNA that is encoded by the
HIV-1 virus. These inhibitors are designed to bind to
the polymerase active site of the RT and block further
growth of the rogue DNA. Biologically, HIV-1 excises
NRTIs via two known mechanisms i) the thymidine-
associated mutations (TAMs), comprising mutations
D67N, M41L, L210W, T215Y/F, K70R and K219Q, and
ii) the Q151M complex, comprising mutations Q151M,
A62V, V75I, F77L, and F116Y [17]. We must establish
that the learned Markov blankets cover these mutations.
We analyzed the fifty independently learned BNs
from our cross-validation experiments, and we tallied
the number of times that each mutation was covered
by the learned Markov blankets. Table 1 presents the
findings. From this table, the major mutations are the
D67N and M41L, which are both members of TAMs.
Table 2: Accuracy on the ALL/AML test set.
Method Prediction Accuracy
Weighted Voting [2] 0.85
SVM [29] 0.88
EP [31] 0.91
ARAM [32] 0.94
SVM 0.88
NBayes 0.88
DT 0.91
BN 0.97
BN-NC 0.97
Combinations of TAMs or T69i and TAMs are found in
all Markov blankets, whilst no Q151M complex muta-
tion could be found; this suggests that for TDF, TAMs
are the predominant resistance pathways selected by
HIV-1. Interestingly, L210W always appears in tan-
dem with D67N, the most common mutation in the
Markov blankets. Likewise, the T69i mutation (inser-
tion of dipeptide between positions 69 and 70) always
appears together with TAMs, which qualifies it as a
minor mutation for HIV-1 against TDF. Indeed, bio-
logical experiments have shown that the combination
of T69i and TAMs does provide strong resistance to
all the NRTI drugs [30]. The findings thus successfully
demonstrate that BN learning recovers features known
to possess biological associations with the class variable,
which enables BN-NC to generate biologically meaning-
ful explanations based on nodes in the Markov blankets.
4.2 Acute Leukemia Subtypes Classification
4.2.1 The ALL/AML Data Set We use the same
train-test split (with 38 training and 34 test examples)
as previous works [2, 29, 31, 32] to facilitate compari-
son. Using the entropy-based feature selection and dis-
cretization method, 866 genes in the training set are
partitioned into two to four intervals each, with no cut-
ting points for the others, i.e., just 866 / 7,129 = 12.1%
of the genes are discriminatory among the two subtypes.
Table 2 shows that BN-NC framework generates
just a single misclassification on the 34 test samples
(accuracy 0.97) using 24 genes, which outperforms all
previous reported results on this data set by weighted
voting [2], support vector machines (SVM) [29], emerg-
ing patterns (EP) [31], and adaptive resonance associa-
tive maps (ARAM) [32]. SVM, Naive Bayes classifier
(NBayes) and J4.8 decision tree (DT) made between
three to four misclassifications on the same test exam-
ples using the identical set of genes as BN and BN-NC.
The standard BN without our noise correction per-
Zyxin
Class
CST3CD33CD36
(a) Using 24 genes
Zyxin
Class
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(b) Using 18 genes
Figure 5: Markov blanket in learned BN for ALL/AML.
Table 3: Info. gains and error ests. for genes in Fig 5(a).
Gene-ID Full Description Info. Gain Error Estimate
X95735 Zyxin 0.8680 0.0000
M27891 CST3 Cystatin C 0.7043 0.0000
M23197 CD33 antigen 0.5917 0.0526
M98399 CD36 antigen 0.5917 0.0789
formed very well on the test set. This is possible if the
important genes contain little or no error, in which case
any noise correction would not improve the result. Fig-
ure 5(a) shows the Markov blanket of the learned BN,
consisting of genes Zyxin, CD36 antigen, CD33 anti-
gen and CST3 Cystatin C. The corresponding informa-
tion gains and error estimates discovered by our BN-
NC framework are listed in Table 3. The genes in the
class variable’s Markov blanket in Figure 5(a) overlap
with those that Tan and Pan [32] identified. Specifi-
cally, genes Zyxin and CST3 Cystatin C are consistently
found to be highly discriminatory of leukemia tumors.
With reference to Table 3, these two particular genes
possess high information gain values of 0.868 and 0.704,
respectively. Using our error discovery procedure, no
error is detected for either of these genes, and very lit-
tle error for the other two, which explains the standard
BN’s ability to discriminate tumor subtypes even with
no noise correction. In this case, the insights from BN-
NC in Figure 5(a) and Table 3 show us the underlying
gene interactions and how their inherent noise charac-
teristics affect the BN’s accuracy. More importantly, the
above results show that BN-NC does not overcompen-
sate or indiscriminately assign error estimates to “clean”
features but accurately reports the noise in each feature.
The genes within the Markov blanket of the learned
BN in Figure 5(a) are known to have biological signifi-
cance to acute leukemia, which once again validates that
the BN-NC strategy of explaining BN classifications us-
ing the genes in Markov blanket is biologically sound.
Specifically, Zyxin is a binding partner of transcription
factor ZNF384, which is recurrently involved in ALL
translocations [33]. Moreover, Zyxin is located in chro-
mosome 7, which contains genes related to AML [34].
Table 4: BN-NC explanations for a ALL/AML test case.
(a) Without noise correction
Class is AML (p = 0.517), as
Zyxin ≤ 994 (p = 1.0),
ADM > 185 (p = 1.0), and
ELA2 > 197.5 (p = 1.0).
(b) After noise correction
Class is ALL (p=0.639), as
Zyxin ≤ 994 (p = 1.0),
ADM > 185 (p = 0.8), and
ELA2 > 197.5 (p = 0.8).
CST3 Cystatin C is an endogenous protein inhibitor of
cathepsins, related to the etiology or the cause of ALL
and AML [34]. In addition, CD33 antigen in chromo-
some 19q13.3 has been used for targeted antibody ther-
apy to destroy AML cells [35], and high CD36 antigen
expressions are associated with low AML survival [36].
Using 18 genes, BN learning displaces CST3 Cys-
tatin C from the target’s Markov blanket (Figure 5(b)),
resulting in five misclassifications on the test set (accu-
racy 0.85). BN-NC discovers an error rate of 0.0789 for
both ADM Adrenomedullin and ELA2 Elastatse 2 neu-
trophil, which are the two genes that are now captured
in the Markov blanket apart from Zyxin, and BN-NC
corrected two of the misclassifications automatically.
The genes ADM Adrenomedullin and ELA2 Elas-
tatse 2 neutrophil are also biologically associated with
leukemia. Adrenomedullin production is correlated with
differentiation in human leukemia cell lines and periph-
eral blood monocytes [37], while Elastatse 2 neutrophil
is a myeloid-restricted protein highly expressed in AML
cells and is a potential protein vaccine against AML [38].
Table 4 shows the explanations generated by BN-
NC for a test case, before and after the noise correction.
The explanations provide us with insights to the BN
inferences that would otherwise not be visible. First,
the same BN classifier has actually reversed its diagno-
sis after our error discovery and likelihoods estimation
procedure enables it to properly account for the uncer-
tainty in the Markov values. Second, this change in tack
is actually due to the BN’s lower beliefs in the values
of genes ADM Adrenomedullin and ELA2 Elastatse 2
neutrophil. Finally, BN-NC predicts ALL with a higher
confidence (0.639) than it had predicted AML (0.517),
which matches the fact that this is an ALL sample.
4.2.2 The Pediatric ALL Data Set There are 215
training and 112 test cases in the Pediatric ALL data
set. Yeoh et al. [23] used support vector machines
(SVM) as the classifier for this problem and correlation-
based feature selection (CFS) for selecting discrimina-
tory genes. They reported that the number of genes that
gave the best test prediction accuracy varied from one
to twenty among the six subtypes. For example, a single
gene was sufficient to differentiate samples belonging to
Table 5: Test prediction accuracy on the Pediatric ALL
test sets. The best results for each subtype are bolded.
Subtype SVM [23] SVM NB DT BN BN-NC
T-ALL 1 1 1 1 1 1
E2A-PBX1 1 1 1 1 0.99 1
TEL-AML1 0.99 0.98 1 0.96 0.99 1
BCR-ABL 0.97 0.99 0.98 0.98 0.98 0.99
MLL 0.98 1 1 0.97 1 1
Hype.>50 0.96 0.93 0.95 0.93 0.96 0.96
subtypes T-ALL and E2A-PBX1, but seven to as many
as twenty genes were required to accurately predict the
other four subtypes. For BN, by cross-validating using
the training examples (results not shown), we find that
using twelve to fifteen most-informative genes is optimal
for all the six subtypes, and we use the identical sets of
genes to compare the standard BN, BN-NC, J4.8 DT,
SVM and the NBayes methods in all of our experiments.
As shown in Table 5, BN-NC outperforms the Sup-
port Vector Machine (SVM) in [23] on the same train-
test split for the three subtypes TEL-AML1, BCR-ABL,
and MLL, and it outperforms SVM in our experiments
for subtypes TEL-AML1 and Hype.>50. BN-NC out-
performs Naive Bayes (NBayes, denoted in the table as
“NB”) for subtypes BCR-ABL and Hype.>50, and is
more accurate than J4.8 Decision Tree (DT) in four sub-
types. Compared to standard BN (denoted in the table
as “BN”), BN-NC performed superiorly in classifying
subtypes E2A-PBX1, TEL-AML1 and BCR-ABL. The
results show that, by effectively exploiting the feature
dependencies in the training data, BN-NC was indeed
able to predict better on the same test set compared to
SVM, NBayes, DT and standard BN, all of which do not
discover nor account for feature noise within the data.
Overall, our BN-NC outperforms all the other methods
for the six Pediatric ALL subtype classification tasks.
Next, we look to TEL-AML1 for an example of how
feature interactions and noise corrections are directly
interpretable under the BN-NC framework. With refer-
ence to Table 5, BN-NC achieved perfect test prediction
for TEL-AML1. The BN learned from the training set
is shown in Figure 6, where the Markov blanket for the
target node Class is demarcated. This Markov blanket
for the Class variable shields it from the other nodes and
completely predicts its behavior. Our proposed BN-NC
framework exploits this fact to auto-generate explana-
tions for the BN predictions and any noise correction.
Tables 6(a) and 6(b) show the BN-NC explanations
for the BN prediction on a test example of TEL-AML1,
before and after noise correction. Similar to what we
have seen from the ALL/AML experiments earlier, noise
Table 6: BN-NC explanations for TEL-AML1 test case.
(a) Without noise correction
Class is TEL (p = 0.773), as
a38652 = 0 (p = 1.0),
a36239 = 2 (p = 1.0),
a1077 = 1 (p = 1.0),
a38203 = 0 (p = 1.0),
a35614 = 0 (p = 1.0),
a32224 = 0 (p = 1.0),
a37780 = 1 (p = 1.0),
a38578 = 1 (p = 1.0),
a41442 = 0 (p = 1.0),
a36985 = 1 (p = 1.0), and
a1299 = 2 (p = 1.0).
(b) After noise correction
Class is not TEL (p = 0.919), as
a38652 = 0 (p = 1.0),
a36239 = 2 (p = 0.6),
a1077 = 1 (p = 0.8),
a38203 = 0 (p = 1.0),
a35614 = 0 (p = 1.0),
a32224 = 0 (p = 1.0),
a37780 = 0 (p = 0.7),
a38578 = 1 (p = 0.7),
a41442 = 0 (p = 1.0),
a36985 = 1 (p = 0.6), and
a1299 = 0 (p = 0.8).
(c) Gene value correction by BN-NC
a37780 is corrected from (a37780 = 1) to (a37780 = 0), as
Given a38203 = 0 and a35665 = 0,
(a37780 = 0) has p = 0.7,
while (a37780 = 1) only has p = 0.3.
a1299 is corrected from (a1299 = 2) to (a1299 = 0), as
Given a35614 = 0,
(a1299 = 0) has p = 0.8,
while (a1299 = 2) only has p = 0.1.
correction enables the BN to consider the uncertainties
in the gene measurements, to correctly classify this par-
ticular test example as not TEL (with a much higher
confidence than before). The ability to reliably esti-
mate the error rate of each gene and translate it into
likelihoods estimations for proper consideration by the
BN classifier is very important. In this case, as shown
by the explanation in Table 6(b), more than half of the
Markov nodes in Figure 6 (for example, gene a36239 and
gene a1077) exhibit certain degree of uncertainty that
would have been overlooked by the BN (Table 6(a)) if
not for our noise correction. BN-NC auto-generates the
explanation in Table 6(c) as insight to the corrections in
values of genes a37780 and a1299 during the inference.
To summarize the experimental results, our BN-NC
framework performs more robustly on noisy data com-
pared to BN without noise correction and other compet-
ing methods including Decision Tree (DT), Naive Bayes
(NBayes) and Support Vector Machine (SVM). More-
over, in contrast to methods that do not yield predic-
tive models that are directly interpretable in the form
of graphs or rules (e.g. SVM [29] and lazy classification
methods like k-NN [39]), BN-NC automatically gener-
ates probabilistic rules to explain each BN inference and
any noise correction. Together, the resulting graphical
BN model and the auto-generated explanations help to
make the BN classifications more comprehensible and
offer us new insights to the feature interaction processes.
Markov Blanket of Class
Figure 6: BN learned from training set for TEL-AML1.
5 Conclusion
By effectively capturing and exploiting feature depen-
dencies from noisy biomedical data, we have introduced
the BN-NC framework, a coherent knowledge discov-
ery process for noisy biomedical data classification, and
demonstrated its efficacy using a number of real-world
data sets. The capability to automatically identify noisy
features and thereafter correct their values in real-time
during the prediction, as well as to explain both the clas-
sification outcomes and the noise corrections underlying
those decisions, is unique to our proposed framework.
As a key contribution in this paper, we have sought
and found answers to important concerns regarding the
overall efficacy of the proposed BN-NC framework when
applied to biomedical prediction. We have validated em-
pirically using a HIV-1 drug resistance prediction data
set that i) the noise discovery procedure correctly iden-
tifies noisy features, ii) the BN-NC framework consis-
tently outperforms state-of-the-art classifiers including
decision tree, naive Bayes and support vector machine
in overcoming noisy feature values, and iii) the features
within the target variable’s Markov blanket have known
target associations that facilitate auto-generation of bi-
ologically meaningful explanations by BN-NC. In ad-
dition, we have validated using two real-world leukemia
subtype classification data sets that BN-NC indeed per-
forms at the frontier of existing methods on noisy DNA
microarray data, which represents a prevalent source of
biomedical data used for medical classification today.
The proposed BN-NC framework is readily applica-
ble to noisy biomedical classification tasks, and it also
extends to other domains suffering from noisy features.
Moving ahead, we shall continue to research and develop
effective solutions to overcome problems posed by data
noise. Issues to be investigated include the performance
of alternative feature selection techniques such as the
Fisher criterion adopted in [32], and the learning perfor-
mance of existing metric or constraint-based algorithms
for Bayesian network learning from data [13]. We hope
that our good results and the biologically-sound causal
models presented in this work would alleviate some of
the concerns of researchers regarding the ability to learn
correct BN structures, and this would encourage more
of us to apply BN learning from data to other problems.
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